What: Orion Pharma tutorials
When: Sunday-Monday, 26-27th of May
Where: Heart Failure 2019 congress, Megaron - Athens International Conference Centre, Athens, Greece
More information: https://www.escardio.org/Congresses-&-Events/Heart-Failure
The use of inotropes for correcting hemodynamic dysfunction in patients with congestive heart failure has been described over many decades.
However, negative or insufficient data has been collected on the effects of cardiac glycosides, cathecolamines, and phosphodiesthrase inhibitors on quality of life and survival.
More recently, the calcium sensitizer and potassium channel opener levosimendan has been proposed as a safer inodilator.
This series of tutorials focuses on how to use levosimendan safely and effectively in acute and advanced heart failure.
The same program with same timings was held both on Sunday and Monday.
The Acute Heart Failure settings
The Advanced Heart Failure settings
Differential renal effects of vasoactive drugs
AHF or CS as a consequence of Acute Coronary Syndrome